Puma Biotechnology (PBYI) Finished Goods (2020 - 2026)
Puma Biotechnology's (PBYI) quarterly Finished Goods came in at $767000.0 in Q1 2026, up 36.72% YoY from $561000.0 in Q1 2025, and down 20.1% on a QoQ basis from $960000.0 in Q4 2025.
Puma Biotechnology (PBYI) Finished Goods (2020 - 2026) Analysis & Trends
Puma Biotechnology (PBYI) has 7 years of Finished Goods data on file, last reported at $767000.0 in Q1 2026.
- Quarterly Finished Goods rose 36.72% year-over-year to $767000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $767000.0 (up 36.72% YoY) and the FY2025 annual result came in at $960000.0, up 22.61% from the prior year.
- Finished Goods slipped to $767000.0 in Q1 2026, from $960000.0 in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $1.6 million in Q1 2022 to a low of $186000.0 in Q4 2022.
- A 5-year average of $696000.0 and a median of $642000.0 in 2022 frame the typical range for Finished Goods.
- Annual changes were most pronounced in 2022 — Finished Goods plunged 83.9% — and 2023, when it jumped 204.84%.
- Tracing PBYI's Finished Goods over 5 years: stood at $186000.0 in 2022, then jumped by 204.84% to $567000.0 in 2023, then soared by 38.1% to $783000.0 in 2024, then increased by 22.61% to $960000.0 in 2025, then decreased by 20.1% to $767000.0 in 2026.
- The last three Finished Goods figures came in at $767000.0 (Q1 2026), $960000.0 (Q4 2025), and $439000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Puma Biotechnology | 451.24 Mn | 357.33 Mn | 44.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.05 Mn |
| Mar 31, 2026 | 767,000.00 |
| Dec 31, 2025 | 960,000.00 |
| Sep 30, 2025 | 439,000.00 |
| Jun 30, 2025 | 762,000.00 |
| Mar 31, 2025 | 561,000.00 |
| Dec 31, 2024 | 783,000.00 |
| Sep 30, 2024 | 457,000.00 |
| Jun 30, 2024 | 663,000.00 |
| Mar 31, 2024 | 488,000.00 |
| Dec 31, 2023 | 567,000.00 |
| Sep 30, 2023 | 978,000.00 |
| Jun 30, 2023 | 618,000.00 |
| Mar 31, 2023 | 850,000.00 |
| Dec 31, 2022 | 186,000.00 |
| Sep 30, 2022 | 482,000.00 |
| Jun 30, 2022 | 642,000.00 |
| Mar 31, 2022 | 1.63 Mn |
| Dec 31, 2021 | 1.16 Mn |
| Dec 31, 2020 | 765,000.00 |